QC
IART icon

Quadrature Capital’s Integra LifeSciences IART Stock Holding History

Quadrature Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-27,354
Closed -$969K – 1303
2024
Q1 		$969K Buy
27,354
+12,290
+82% +$492K 0.02% 491
2023
Q4 		$656K Sell
15,064
-18,658
-55% -$734K 0.01% 577
2023
Q3 		$1.29M Buy
33,722
+5,726
+20% +$241K 0.03% 367
2023
Q2 		$1.15M Buy
+27,996
New +$1.35M 0.03% 402
2020
Q2 		– Sell
-12,032
Closed -$537K – 695
2020
Q1 		$537K Buy
12,032
+5,546
+86% +$291K 0.13% 218
2019
Q4 		$378K Buy
+6,486
New +$386K 0.01% 372
2019
Q3 		– Sell
-8,283
Closed -$463K – 608
2019
Q2 		$463K Buy
8,283
+3,215
+63% +$166K 0.03% 319
2019
Q1 		$283K Buy
+5,068
New +$258K 0.02% 422
2018
Q3 		– Sell
-6,249
Closed -$403K – 668
2018
Q2 		$403K Buy
+6,249
New +$387K 0.04% 352

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Quadrature Capital's IART Position: Q2 2024 in Review

Quadrature Capital sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 27,354 shares — an estimated $969K sold.

Quadrature Capital first reported a position in IART in Q2 2018 and held it in 9 quarters. The position peaked at $1.29M in Q3 2023. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Quadrature Capital reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Quadrature Capital sold 27,354 Integra LifeSciences shares in Q2 2024, an estimated $969K.
  • Quadrature Capital first reported a position in Integra LifeSciences in Q2 2018 and held it in 9 quarters.
  • Quadrature Capital's Integra LifeSciences position peaked at $1.29M in Q3 2023.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Quadrature Capital's 13F filing for Q2 2024, filed 14 Aug 2024.